Professional
Added to YB: 2025-05-07
Pitch date: 2025-04-22
ABT [neutral]
Abbott Laboratories
-1.96%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Market Cap
$218.2B
Pitch Price
$131.04
Price Target
N/A
Dividend
1.88%
EV/EBITDA
18.47
P/E
15.76
EV/Sales
5.10
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Polen Global Growth Portfolio Holding: Abbott Laboratories
ABT (holding update): Top relative contributor, +16% in Q4. Moving past COVID headwinds, overcoming 2024 NEC litigation in infant formula. Expect low-teens EPS growth for several years as one of world's most durable MedTech companies, with share price now reflecting strong fundamentals heading into 2025.
Read full article (1 min)